David Cohen is a leader in Kaufman Hall’s Mergers and Acquisitions practice. He advises healthcare executives nationwide on mergers, acquisitions, divestitures, joint ventures, investment transactions, strategic options assessments, valuations, fairness opinions, and other partnership initiatives.

With 20 years of healthcare experience, David has provided sell-side and buy-side advisory services to companies in various sectors, including acute care, air medical transport, managed care, laboratory operations, pharmaceuticals, and medical technology. 

Prior to Kaufman Hall, he was as an investment banker with Oppenheimer, where he was the Managing Director responsible for healthcare M&A transactions. He previously held positions with Morgan Stanley, Merrill Lynch, Lehman Brothers, Motorola, and an intelligence unit of the Israel Defense Forces. David holds an M.B.A. from New York University.


Mergers & Acquisitions

Insights from David Cohen


Industry Flash Report: Managed Care 2018

Consistent membership and premium growth by U.S. payer markets is expected to continue, according to new Kaufman Hall research. Premiums for the U.S. managed care market were estimated at $2.9 trillion for 2017.

Research Report

Increased For-Profit Funding for Outpatient Expansion Should Put Hospitals on Alert

Recent news about investments in outpatient care among non-traditional competitors should put hospitals and health systems on notice: The nature of healthcare today is generating aggressive competition for patients and physicians. The stakes are high. Remaining competitive will require a planning process that is as nimble and assertive as that of new competitors.